Clinical Epigenetics

Papers
(The TQCC of Clinical Epigenetics is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
The dynamic broad epigenetic (H3K4me3, H3K27ac) domain as a mark of essential genes110
DNA methyltransferase inhibitors combination therapy for the treatment of solid tumor: mechanism and clinical application102
Epigenome-wide association studies: current knowledge, strategies and recommendations83
Blood DNA methylation and COVID-19 outcomes80
Mitochondrial metabolism and DNA methylation: a review of the interaction between two genomes77
Cellular reprogramming and epigenetic rejuvenation66
Novel DNA methylation signatures of tobacco smoking with trans-ethnic effects64
Advances in epigenetic therapeutics with focus on solid tumors62
Effects of metabolic memory on inflammation and fibrosis associated with diabetic kidney disease: an epigenetic perspective59
Epigenetic regulation of inflammation in periodontitis: cellular mechanisms and therapeutic potential56
Sperm DNA methylation epimutation biomarker for paternal offspring autism susceptibility53
Epigenetic alterations and advancement of treatment in peripheral T-cell lymphoma53
Current understanding of epigenetics mechanism as a novel target in reducing cancer stem cells resistance52
Epigenetic modification mechanisms involved in keloid: current status and prospect52
Gene body methylation in cancer: molecular mechanisms and clinical applications52
Epigenetic age acceleration is associated with cardiometabolic risk factors and clinical cardiovascular disease risk scores in African Americans49
Finding an easy way to harmonize: a review of advances in clinical research and combination strategies of EZH2 inhibitors46
DNA methylation biomarkers of myocardial infarction and cardiovascular disease45
Characterising sex differences of autosomal DNA methylation in whole blood using the Illumina EPIC array44
Tackling tumor microenvironment through epigenetic tools to improve cancer immunotherapy44
Genetic, epigenetic, and environmental factors controlling oxytocin receptor gene expression44
DNA methylation and lipid metabolism: an EWAS of 226 metabolic measures44
Clinical epigenetics settings for cancer and cardiovascular diseases: real-life applications of network medicine at the bedside42
DNA methylation of blood cells is associated with prevalent type 2 diabetes in a meta-analysis of four European cohorts42
SMYD3: a regulator of epigenetic and signaling pathways in cancer42
Hypoxia promotes the metastasis of pancreatic cancer through regulating NOX4/KDM5A-mediated histone methylation modification changes in a HIF1A-independent manner41
The ENmix DNA methylation analysis pipeline for Illumina BeadChip and comparisons with seven other preprocessing pipelines41
A urine-based DNA methylation assay to facilitate early detection and risk stratification of bladder cancer40
Developmental cannabidiol exposure increases anxiety and modifies genome-wide brain DNA methylation in adult female mice40
Methylated circulating tumor DNA as a biomarker for colorectal cancer diagnosis, prognosis, and prediction39
DNA methylation mediates the effect of maternal smoking on offspring birthweight: a birth cohort study of multi-ethnic US mother–newborn pairs39
The dark side of histones: genomic organization and role of oncohistones in cancer39
Liquid biopsies based on DNA methylation as biomarkers for the detection and prognosis of lung cancer38
The role of epigenetic mechanisms in the regulation of gene expression in the cyclical endometrium38
Association of peripheral blood DNA methylation level with Alzheimer’s disease progression36
DNA methylation signatures of incident coronary heart disease: findings from epigenome-wide association studies36
Assessment of differentially methylated loci in individuals with end-stage kidney disease attributed to diabetic kidney disease: an exploratory study35
Pembrolizumab plus azacitidine in patients with chemotherapy refractory metastatic colorectal cancer: a single-arm phase 2 trial and correlative biomarker analysis34
Epigenetic reprogramming of cell identity: lessons from development for regenerative medicine33
H3K36 trimethylation-mediated biological functions in cancer33
DNA methylation and gene expression integration in cardiovascular disease32
A review of epigenetic changes in asthma: methylation and acetylation32
Characteristics of epigenetic aging across gestational and perinatal tissues32
Epigenetic modifications in muscle regeneration and progression of Duchenne muscular dystrophy31
Ethical implications of epigenetics in the era of personalized medicine31
The role of DNA methylation in syndromic and non-syndromic congenital heart disease31
Changes in DNA methylation profiles of myalgic encephalomyelitis/chronic fatigue syndrome patients reflect systemic dysfunctions30
Association of cardiovascular health and epigenetic age acceleration30
DNA methylation epi-signature is associated with two molecularly and phenotypically distinct clinical subtypes of Phelan-McDermid syndrome30
An EPIC predictor of gestational age and its application to newborns conceived by assisted reproductive technologies30
Lifetime exposure to smoking, epigenetic aging, and morbidity and mortality in older adults30
STAT1 epigenetically regulates LCP2 and TNFAIP2 by recruiting EP300 to contribute to the pathogenesis of inflammatory bowel disease29
Synergistic effects of type I PRMT and PARP inhibitors against non-small cell lung cancer cells28
Differential DNA methylation and changing cell-type proportions as fibrotic stage progresses in NAFLD28
Guidelines for pre-analytical conditions for assessing the methylation of circulating cell-free DNA28
High-resolution analyses of human sperm dynamic methylome reveal thousands of novel age-related epigenetic alterations28
The role of epigenetic modifications for the pathogenesis of Crohn's disease28
Male obesity impacts DNA methylation reprogramming in sperm27
Associations between indicators of socioeconomic position and DNA methylation: a scoping review27
Epigenetic age is associated with baseline and 3-year change in frailty in the Canadian Longitudinal Study on Aging27
DNA methylation: a potential mediator between air pollution and metabolic syndrome27
Epigenetic targeting of the ACE2 and NRP1 viral receptors limits SARS-CoV-2 infectivity27
Lifestyle weight-loss intervention may attenuate methylation aging: the CENTRAL MRI randomized controlled trial26
Sensitive detection of colorectal cancer in peripheral blood by a novel methylation assay26
Skeletal muscle methylome and transcriptome integration reveals profound sex differences related to muscle function and substrate metabolism26
DNA methylation profiling for molecular classification of adult diffuse lower-grade gliomas26
Cell-type heterogeneity: Why we should adjust for it in epigenome and biomarker studies26
Multi-omics integration identifies key upstream regulators of pathomechanisms in hypertrophic cardiomyopathy due to truncating MYBPC3 mutations25
BET protein inhibitor apabetalone (RVX-208) suppresses pro-inflammatory hyper-activation of monocytes from patients with cardiovascular disease and type 2 diabetes25
Prenatal metal exposure, cord blood DNA methylation and persistence in childhood: an epigenome-wide association study of 12 metals25
DNA methylation mediates the association between breastfeeding and early-life growth trajectories24
Cardiovascular health and four epigenetic clocks24
Identification of DNA methylation markers for early detection of CRC indicates a role for nervous system-related genes in CRC24
NEFM DNA methylation correlates with immune infiltration and survival in breast cancer24
Reproductive technologies, female infertility, and the risk of imprinting-related disorders23
Physical activity specifically evokes release of cell-free DNA from granulocytes thereby affecting liquid biopsy23
Father-to-offspring transmission of extremely long NOTCH2NLC repeat expansions with contractions: genetic and epigenetic profiling with long-read sequencing23
Gender-affirming hormone therapy induces specific DNA methylation changes in blood23
Genome-wide DNA methylome analysis identifies methylation signatures associated with survival and drug resistance of ovarian cancers23
Longitudinal data in peripheral blood confirm that PM20D1 is a quantitative trait locus (QTL) for Alzheimer’s disease and implicate its dynamic role in disease progression23
Trans-acting genetic variants causing multilocus imprinting disturbance (MLID): common mechanisms and consequences22
Folic acid intervention during pregnancy alters DNA methylation, affecting neural target genes through two distinct mechanisms22
Bladder cancer detection in urine using DNA methylation markers: a technical and prospective preclinical validation22
The impact of CBP expression in estrogen receptor-positive breast cancer22
Non-invasive detection of endometrial cancer by DNA methylation analysis in urine22
Impact of vitamin C supplementation on placental DNA methylation changes related to maternal smoking: association with gene expression and respiratory outcomes22
Childhood-onset dystonia-causing KMT2B variants result in a distinctive genomic hypermethylation profile22
UHRF1 downregulation promotes T follicular helper cell differentiation by increasing BCL6 expression in SLE22
The tumor suppressor Zinc finger protein 471 suppresses breast cancer growth and metastasis through inhibiting AKT and Wnt/β-catenin signaling22
Circulating tumor DNA methylation marker MYO1-G for diagnosis and monitoring of colorectal cancer22
Clinical evaluation of Bladder CARE, a new epigenetic test for bladder cancer detection in urine samples21
METTL3-dependent MALAT1 delocalization drives c-Myc induction in thymic epithelial tumors21
Triage of hrHPV-positive women: comparison of two commercial methylation-specific PCR assays21
Characterisation of ethnic differences in DNA methylation between UK-resident South Asians and Europeans20
Discovery and validation of methylation signatures in blood-based circulating tumor cell-free DNA in early detection of colorectal carcinoma: a case–control study20
DNA methylation analysis of tumor suppressor genes in liquid biopsy components of early stage NSCLC: a promising tool for early detection20
Does the epigenetic clock GrimAge predict mortality independent of genetic influences: an 18 year follow-up study in older female twin pairs20
Leveraging epigenetics to enhance the efficacy of immunotherapy20
A novel DNA methylation signature is associated with androgen receptor activity and patient prognosis in bone metastatic prostate cancer19
Blood and skeletal muscle ageing determined by epigenetic clocks and their associations with physical activity and functioning19
Persistent blood DNA methylation changes one year after SARS-CoV-2 infection19
Impact of BMI and waist circumference on epigenome-wide DNA methylation and identification of epigenetic biomarkers in blood: an EWAS in multi-ethnic Asian individuals19
DNA hypermethylation contributes to colorectal cancer metastasis by regulating the binding of CEBPB and TFCP2 to the CPEB1 promoter19
Epigenetic mechanisms underlying prostate cancer radioresistance19
Predictive biomarkers and potential drug combinations of epi-drugs in cancer therapy19
DNAm-based signatures of accelerated aging and mortality in blood are associated with low renal function19
Different methylation signatures at diagnosis in patients with high-risk myelodysplastic syndromes and secondary acute myeloid leukemia predict azacitidine response and longer survival19
Evaluation of a panel of tumor-specific differentially-methylated DNA regions in IRF4, IKZF1 and BCAT1 for blood-based detection of colorectal cancer19
DNA methylation impact on Fabry disease18
LncRNA STXBP5-AS1 suppresses stem cell-like properties of pancreatic cancer by epigenetically inhibiting neighboring androglobin gene expression18
Spatial epi-proteomics enabled by histone post-translational modification analysis from low-abundance clinical samples18
Abnormal methylation characteristics predict chemoresistance and poor prognosis in advanced high-grade serous ovarian cancer18
Therapeutic potential of inhibiting histone 3 lysine 27 demethylases: a review of the literature18
Micro-RNA-125a mediates the effects of hypomethylating agents in chronic myelomonocytic leukemia17
BRG1 knockdown inhibits proliferation through multiple cellular pathways in prostate cancer17
Predicting male fertility from the sperm methylome: application to 120 bulls with hundreds of artificial insemination records17
DNA methylome profiling reveals epigenetic regulation of lipoprotein-associated phospholipase A2 in human vulnerable atherosclerotic plaque17
Dynamic changes in chromatin accessibility, altered adipogenic gene expression, and total versus de novo fatty acid synthesis in subcutaneous adipose stem cells of normal-weight polycystic ovary syndr17
Longitudinal analysis of individual cfDNA methylome patterns in metastatic prostate cancer17
Profile of copper-associated DNA methylation and its association with incident acute coronary syndrome17
HDAC8 suppresses the epithelial phenotype and promotes EMT in chemotherapy-treated basal-like breast cancer17
0.019665002822876